The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant trastuzumab (H), pertuzumab (P), and chemotherapy versus trastuzumab emtansine (T-DM1) and P in human epidermal growth factor receptor 2 (HER2)-positive breast cancer (BC): Final outcome results from the phase III KRISTINE study.
 
Sara A. Hurvitz
No Relationships to Disclose
 
Miguel Martin
No Relationships to Disclose
 
Kyung Hae Jung
No Relationships to Disclose
 
Chiun-Sheng Huang
No Relationships to Disclose
 
Nadia Harbeck
No Relationships to Disclose
 
Vicente Valero
No Relationships to Disclose
 
Daniil Stroyakovskiy
No Relationships to Disclose
 
Hans Wildiers
No Relationships to Disclose
 
Mario Campone
No Relationships to Disclose
 
Jean-Francois Boileau
No Relationships to Disclose
 
Matthias W. Beckmann
No Relationships to Disclose
 
Karen Afenjar
No Relationships to Disclose
 
Gonzalo Spera
No Relationships to Disclose
 
Vanesa Lopez Valverde
No Relationships to Disclose
 
Chunyan Song
No Relationships to Disclose
 
Thomas Boulet
No Relationships to Disclose
 
Joseph A. Sparano
No Relationships to Disclose
 
William Fraser Symmans
No Relationships to Disclose
 
Alastair Mark Thompson
No Relationships to Disclose
 
Dennis J. Slamon
No Relationships to Disclose